Correlation Between Moleculin Biotech and Adial Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Adial Pharmaceuticals, you can compare the effects of market volatilities on Moleculin Biotech and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Adial Pharmaceuticals.
Diversification Opportunities for Moleculin Biotech and Adial Pharmaceuticals
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Moleculin and Adial is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Adial Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Adial Pharmaceuticals go up and down completely randomly.
Pair Corralation between Moleculin Biotech and Adial Pharmaceuticals
Given the investment horizon of 90 days Moleculin Biotech is expected to under-perform the Adial Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Moleculin Biotech is 1.87 times less risky than Adial Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Adial Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 219.00 in Adial Pharmaceuticals on August 26, 2024 and sell it today you would lose (118.00) from holding Adial Pharmaceuticals or give up 53.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Moleculin Biotech vs. Adial Pharmaceuticals
Performance |
| Timeline |
| Moleculin Biotech |
| Adial Pharmaceuticals |
Moleculin Biotech and Adial Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Moleculin Biotech and Adial Pharmaceuticals
The main advantage of trading using opposite Moleculin Biotech and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
| Adial Pharmaceuticals vs. Transcode Therapeutics | Adial Pharmaceuticals vs. Aditxt Inc | Adial Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Adial Pharmaceuticals vs. Avenue Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |